Michael Reiß

6.7k total citations · 1 hit paper
86 papers, 5.4k citations indexed

About

Michael Reiß is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Michael Reiß has authored 86 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 30 papers in Oncology and 14 papers in Pathology and Forensic Medicine. Recurrent topics in Michael Reiß's work include TGF-β signaling in diseases (30 papers), Pancreatic and Hepatic Oncology Research (9 papers) and Genetic factors in colorectal cancer (8 papers). Michael Reiß is often cited by papers focused on TGF-β signaling in diseases (30 papers), Pancreatic and Hepatic Oncology Research (9 papers) and Genetic factors in colorectal cancer (8 papers). Michael Reiß collaborates with scholars based in United States, Germany and Netherlands. Michael Reiß's co-authors include Bruce G. Haffty, Qifeng Yang, Lyndsay N. Harris, Thomas Kearney, Deborah Toppmeyer, Susan A. Higgins, Joanne B. Weidhaas, Rebecca G. Wells, Antoinette R. Tan and Wen Xie and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Michael Reiß

84 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Locoregional Relapse and Distant Metastasis in Conservatively Managed Triple Negative Early-Stage Breast Cancer

2006 874 citations Bruce G. Haffty, Michael Reiß et al. profile →

Peers

Countries citing papers authored by Michael Reiß

Since Specialization

Citations

This map shows the geographic impact of Michael Reiß's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Reiß with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Reiß more than expected).

Fields of papers citing papers by Michael Reiß

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Reiß. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Reiß. The network helps show where Michael Reiß may publish in the future.

Co-authorship network of co-authors of Michael Reiß

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Reiß. A scholar is included among the top collaborators of Michael Reiß based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Reiß. Michael Reiß is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phase I Study of GC1008 (Fresolimumab): A Human Anti-Transforming Growth Factor-Beta (TGFβ) Monoclonal Antibody in Patients with Advanced Malignant Melanoma or Renal Cell Carcinoma 2014 ·PLoS ONE ·John C. Morris, Antoinette R. Tan, Thomas Olencki, Geoffrey I. Shapiro, Bruce J. Dezube, Michael Reiß, Frank J. Hsu, Jay A. Berzofsky, Donald P. Lawrence	352
2	Identification of Function for CD44 Intracytoplasmic Domain (CD44-ICD) 2012 ·Journal of Biological Chemistry ·Karl E. Miletti-González, Kyle A. Murphy, (unknown), (unknown), Roman Wernyj, Swayamjot Kaur, Gregory Miles, Elaine Hsuen Lim, (unknown), Marina Chekmareva, Debra S. Heller, David J. Foran, Wenjin Chen, Michael Reiß, Elisa V. Bandera, Kathleen W. Scotto, Lorna Rodríguez-Rodríguez	106
3	Abstract #5667: ADAMTS1 and MMP1 promote breast cancer bone metastasis through a bone stromal cell-mediated osteolytic signaling cascade 2009 ·Cancer Research ·Xin Lü, Qiongqing Wang, Catherine Van Poznak, Martin Fleisher, Michael Reiß, Joan Massagué, Yibin Kang	2
4	Promoter-independent regulation of vimentin expression in mammary epithelial cells by val12 ras and TGFβ 2007 ·Experimental Cell Research ·(unknown), (unknown), (unknown), Michael Reiß, Susan R. Rittling	16
5	Inhibition of Growth and Metastasis of Mouse Mammary Carcinoma by Selective Inhibitor of Transforming Growth Factor-β Type I Receptor Kinase In vivo 2006 ·Clinical Cancer Research ·Rongrong Ge, (unknown), Partha Ray, Edmund C. Lattime, Susan R. Rittling, Satya Medicherla, Andy Protter, Alison Murphy, (unknown), Sundeep Dugar, George F. Schreiner, Nicola Barnard, Michael Reiß	123
6	Singultus: Hinweis auf atypischen Herzinfarkt? 2006 ·MMW - Fortschritte der Medizin ·Michael Reiß, Gilfe Reiß	1
7	Gene expression profiling changes induced by a novel Gemini Vitamin D derivative during the progression of breast cancer 2006 ·Biochemical Pharmacology ·Hong Jin Lee, Hao Liu, Catherine Goodman, Yan Ji, Hubert Maehr, Milan R. Uskoković, Daniel A. Notterman, Michael Reiß, Nanjoo Suh	55
8	Primary aspergillosis of the sphenoid sinus with pituitary invasion – a rare differential diagnosis of sellar lesions 2006 ·Acta Neurochirurgica ·(unknown), Michael Reiß, (unknown), Kartik Krishnan, Gabriele Schackert	21
9	Smad2 and Smad3 Play Different Roles in Rat Hepatic Stellate Cell Function and α-Smooth Muscle Actin Organization 2005 ·Molecular Biology of the Cell ·Masayuki Uemura, E. Scott Swenson, (unknown), Frank J. Giordano, Michael Reiß, Rebecca G. Wells	134
10	Five-Year Update of an Expanded Phase II Study of Dose-Dense and -Intense Doxorubicin, Paclitaxel and Cyclophosphamide (ATC) in High-Risk Breast Cancer 2005 ·Oncology ·Maysa Abu‐Khalaf, (unknown), Keita Ebisu, (unknown), (unknown), Gina G. Chung, Michael P. DiGiovanna, Bruce G. Haffty, (unknown), Leonard R. Farber, (unknown), Michael Reiß, Daniel Zelterman, Barbara Burtness	8
11	Amelioration of Radiation-induced Fibrosis 2004 ·Journal of Biological Chemistry ·Sandhya Xavier, Ester Piek, Makiko Fujii, Delphine Javelaud, Alain Mauviel, (unknown), A. Samuni, Angelina Felici, Michael Reiß, Shai Yarkoni, Anastasia L. Sowers, James B. Mitchell, Anita B. Roberts, Angelo Russo	170
12	Sequential High-Dose Alkylating Therapy and Stem Cell Support for High-Risk Stage III Breast Cancer 2003 ·The Breast Journal ·(unknown), Michal G. Rose, Amanda Psyrri, (unknown), (unknown), (unknown), Christine A. Holtkamp, (unknown), (unknown), Edward L. Snyder, Dennis Cooper, Bruce G. Haffty, Michael Reiß, Barbara Burtness	2
13	TGF-β and cancer 1999 ·Microbes and Infection ·Michael Reiß	107
14	Ocular Dominance: Some Family Data 1997 ·Laterality Asymmetries of Body Brain and Cognition ·Michael Reiß, Gilfe Reiß	54
15	Transforming growth factor-β in breast cancer: A working hypothesis 1997 ·Breast Cancer Research and Treatment ·Michael Reiß, Mary Helen Barcellos‐Hoff	128
16	Terfenadine (seldane®): A new drug for restoring sensitivity to multidrug resistant cancer cells 1993 ·Biochemical Pharmacology ·William N. Hait, Joan Gesmonde, John R. Murren, Jin‐Ming Yang, (unknown), Michael Reiß	48
17	On temporal sequence storage 1991 ·Michael Reiß, J.G. Taylor	1
18	Extracellular calcium‐dependent regulation of transmembrane calcium fluxes in murine keratinocytes 1991 ·Journal of Cellular Physiology ·Michael Reiß, (unknown), (unknown)	31
19	Bovine Papillomavirus Type I Induces Resistance to Ca⁺⁺-Induced Terminal Differentiation in Murine Keratinocytes 1989 ·PubMed ·Michael Reiß, Daniel DiMaio, Theresa Zibello	6
20	Requiem for an "Independent Remedy": The Civil Rights Acts of 1866 and 1971 as Remedies for Employment Discrimination. 1977 ·Michael Reiß	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact